- Home
- IMRX vs PFL Comparison
IMRX vs PFL Comparison
Compare IMRX & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMRX | PFL |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.3M | 362.1M |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | IMRX | PFL |
|---|---|---|
| Price | $4.96 | $7.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.20 | N/A |
| AVG Volume (30 Days) | ★ 812.2K | 266.8K |
| Earning Date | 03-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | ★ 37.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $7.11 |
| 52 Week High | $10.08 | $8.70 |
Technical Indicators
Market Signals| Indicator | IMRX | PFL |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 29.83 |
| Support Level | $4.83 | N/A |
| Resistance Level | $5.36 | $8.49 |
| Average True Range (ATR) | 0.29 | 0.12 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 23.51 | 14.58 |
Price Performance
Historical ComparisonAbout IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.